Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study
E. Ferroni, V. Belleudi, N. Agabiti, M. Di Martino, S. Cascini, U. Kirchmayer, R. Pistelli, E. Patorno, L. Bauleo, G. Formoso, D. Fusco, M. Davoli (Rome, Bologna, Italy; Boston, United States Of America)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Session: Treatment and adherence to treatment of respiratory disease
Session type: Thematic Poster Session
Number: 949
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Ferroni, V. Belleudi, N. Agabiti, M. Di Martino, S. Cascini, U. Kirchmayer, R. Pistelli, E. Patorno, L. Bauleo, G. Formoso, D. Fusco, M. Davoli (Rome, Bologna, Italy; Boston, United States Of America). Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study. Eur Respir J 2013; 42: Suppl. 57, 949
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: